Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by alainmange
Group name PlateformePP2I
Item Type Journal Article
Title Design, Synthesis and Evaluation of a Series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ/TEAD Complex
Creator Bailly et al.
Author Fabrice Bailly
Author Floriane Gibault
Author Manon Sturbaut
Author Mathilde Coevoet
Author Martine Pugnière
Author Ashley Burtscher
Author Patricia Melnyk
Author Wanjin Hong
Author Brian P. Rubin
Author Ajaybabu V. Pobbati
Author Jean-François Guichou
Author Philippe Cotelle
Abstract Starting from our previously reported hit, a series of 1,5-diaryl-1,2,3-triazole-4-carbohydrazones was synthesized and evaluated as inhibitors of the YAP/TAZ-TEAD complex. Binding to hTEAD2 of our compounds was evidenced by nanodifferential scanning fluorimetry and they were also shown by polarization fluorescence to disrupt to some extent YAP-TEAD interaction. They displayed micromolar inhibition in a luciferase gene reporter assay in transfected HEK293T cells and decreased mRNAs levels of TEAD target genes measured by RTqPCR in MDA-MB231 cells. In spite of limiting cytotoxicities, careful analysis of the biological data let emerge some new hits as the starting points for future design aimed at improving YAP-TEAD disruption.
Publication ChemMedChem
Date 2021-05-25
Journal Abbr ChemMedChem
Language eng
DOI 10.1002/cmdc.202100153
ISSN 1860-7187
Library Catalog PubMed
Extra PMID: 34032019
Tags antitumor agents, Hippo pathway, protein-protein interactions, TEAD binding, YAP-TEAD inhibition, author, original, pp2i
Date Added 2021/06/03 - 16:33:17
Date Modified 2021/06/03 - 16:37:15
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés